esmolol has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemson, J; Rongen, GA; van der Hoeven, JG; van Loon, LM; Veltink, PH | 1 |
| Ollila, A; Pettilä, V; Sund, R; Vikatmaa, L; Wilkman, E | 1 |
1 review(s) available for esmolol and Acute Kidney Failure
| Article | Year |
|---|---|
Efficacy and safety of intravenous esmolol for cardiac protection in non-cardiac surgery. A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Bradycardia; Female; Heart; Heart Diseases; Hemodynamics; Humans; Hypotension; Male; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Propanolamines; Protective Agents; Randomized Controlled Trials as Topic; Safety | 2019 |
1 other study(ies) available for esmolol and Acute Kidney Failure
| Article | Year |
|---|---|
β-Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Animals; Female; Heart Rate; Infusions, Intravenous; Lipopolysaccharides; Propanolamines; Renal Circulation; Sheep; Shock, Septic | 2019 |